Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Re
ClinicalTrials.gov study NCT01579630. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC
ClinicalTrials.gov study NCT03333343. IPD Sharing: NO. Countries: 6. Publications: 0.
Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT07379476. IPD Sharing: NO. Countries: 1. Publications: 0.
Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05693090. IPD Sharing: NO. Countries: 1. Publications: 0.
YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
ClinicalTrials.gov study NCT05767892. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With Leptomeningeal Metastases
ClinicalTrials.gov study NCT06926803. IPD Sharing: NO. Countries: 1. Publications: 0.
Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC
ClinicalTrials.gov study NCT05374603. IPD Sharing: YES. Countries: 1. Publications: 0.
Afatinib With CT and RT for EGFR-Mutant NSCLC
ClinicalTrials.gov study NCT01553942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation
ClinicalTrials.gov study NCT02961270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
ClinicalTrials.gov study NCT02355431. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients
ClinicalTrials.gov study NCT04222335. IPD Sharing: NO. Countries: 1. Publications: 0.
ARTEMIS DIANE T790M (An Amino Acid Substitution at Position 790 in EGFR, From a Threonine (T) to a Methionine (M)) Mutation at Hospital Laboratories in Comparison With Central Laboratory
ClinicalTrials.gov study NCT02991274. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients
ClinicalTrials.gov study NCT02454842. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cance
ClinicalTrials.gov study NCT05926180. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT07285148. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03091491. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
ClinicalTrials.gov study NCT05536505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC
ClinicalTrials.gov study NCT05773092. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)
ClinicalTrials.gov study NCT02338011. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phenotypes Associated With Constitutional EGFR Pathogenic Variants
ClinicalTrials.gov study NCT06562491. IPD Sharing: YES. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.